Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

VC Roundup: 2Q Financings Fall As Per-Company Averages Rise

Executive Summary

Second quarter venture capital investment in biotech fell from the same period a year ago, but the total remains near record levels, since some early-stage companies have been able to raise big VC sums.

Advertisement

Related Content

VC Roundup: 2016 US Investment Ends On A Down Note, But Biopharma Has Second-Best Year
VC Roundup: Cleave Raises $37m To Maintain Phase I Momentum, Plus $233.5m In Recent Financings
Biotech VC Funding Rises As Fewer Companies Get More Dollars
ASLAN Keeps Eye On Maximizing Values After Fundraising
Epizyme Appoints CEO
Allergan buys chin fat firm Kythera for $2.1bn
BioNotebook: Second Genome/Pfizer, Merck/Agenus, Endo/Somar, Parion/Gilead, Lightstone Ventures, Kite Pharma, five IPO updates
J&J enters deal with Second Genome to study gut bacteria
The Unlikely Renaissance Of Gene Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register